Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 8,857 shares, a growth of 121.2% from the September 15th total of 4,004 shares. Based on an average trading volume of 46,829 shares, the days-to-cover ratio is presently 0.2 days.
Alpha Tau Medical Price Performance
Shares of NASDAQ DRTSW opened at $3.74 on Tuesday. Alpha Tau Medical has a 12 month low of $0.27 and a 12 month high of $4.62. The business has a 50-day moving average of $3.89 and a 200-day moving average of $2.71.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is an Israeli medical-device company focused on developing cancer treatments based on targeted alpha radiation. Its lead technology, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver localized alpha radiation directly into solid tumors while limiting exposure to surrounding healthy tissue.
Alpha DaRT uses implantable sources containing radium-224. As the material decays, it generates short-range alpha particles intended to damage tumor cells.
Further Reading
- Five stocks we like better than Alpha Tau Medical
- Amazon’s $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?
- Enlisting Capital: Wolfspeed’s Defense Deal
- Ag Equipment’s Recovery Trade Meets Washington’s Scrutiny
- The Pentagon’s $350 Million Quantum Push: Why IonQ Could Benefit More Than D-Wave
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
